These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 17395367

  • 1. Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive.
    Patel O, Dumesny C, Shulkes A, Baldwin GS.
    Cancer Lett; 2007 Aug 28; 254(1):87-93. PubMed ID: 17395367
    [Abstract] [Full Text] [Related]

  • 2. C-terminal fragments of the gastrin-releasing peptide precursor stimulate cell proliferation via a novel receptor.
    Patel O, Dumesny C, Shulkes A, Baldwin GS.
    Endocrinology; 2007 Mar 28; 148(3):1330-9. PubMed ID: 17122080
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP).
    Dumesny C, Patel O, Lachal S, Giraud AS, Baldwin GS, Shulkes A.
    Endocrinology; 2006 Jan 28; 147(1):502-9. PubMed ID: 16223866
    [Abstract] [Full Text] [Related]

  • 4. Gastrin-releasing peptide: different forms, different functions.
    Ischia J, Patel O, Shulkes A, Baldwin GS.
    Biofactors; 2009 Jan 28; 35(1):69-75. PubMed ID: 19319848
    [Abstract] [Full Text] [Related]

  • 5. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K, Kojima A, Morokawa N, Tanabe O, Anzai C, Kawakami M, Eto Y, Yoshimura K.
    J Cancer Res Clin Oncol; 2002 Dec 28; 128(12):633-40. PubMed ID: 12474049
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapy.
    Ischia J, Patel O, Sethi K, Nordlund MS, Bolton D, Shulkes A, Baldwin GS.
    BJU Int; 2015 May 28; 115(5):829-38. PubMed ID: 25130393
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
    Katsuno T, Pradhan TK, Ryan RR, Mantey SA, Hou W, Donohue PJ, Akeson MA, Spindel ER, Battey JF, Coy DH, Jensen RT.
    Biochemistry; 1999 Jun 01; 38(22):7307-20. PubMed ID: 10353842
    [Abstract] [Full Text] [Related]

  • 10. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T, Hocart SJ, Schumann M, Tapia JA, Mantey SA, Coy DH, Tokita K, Katsuno T, Jensen RT.
    Biochem Pharmacol; 2005 Feb 15; 69(4):579-93. PubMed ID: 15670577
    [Abstract] [Full Text] [Related]

  • 11. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
    Guojun W, Wei G, Kedong O, Yi H, Yanfei X, Qingmei C, Yankai Z, Jie W, Hao F, Taiming L, Jingjing L, Rongyue C.
    Endocr Relat Cancer; 2008 Mar 15; 15(1):149-59. PubMed ID: 18310283
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Importance of amino acids of the central portion of the second intracellular loop of the gastrin-releasing Peptide receptor for phospholipase C activation, internalization, and chronic down-regulation.
    Schumann M, Nakagawa T, Mantey SA, Tokita K, Venzon DJ, Hocart SJ, Benya RV, Jensen RT.
    J Pharmacol Exp Ther; 2003 Nov 15; 307(2):597-607. PubMed ID: 12970386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling.
    Farias CB, Lima RC, Lima LO, Flores DG, Meurer L, Brunetto AL, Schwartsmann G, Roesler R.
    Oncology; 2008 Nov 15; 75(1-2):27-31. PubMed ID: 18719351
    [Abstract] [Full Text] [Related]

  • 17. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
    Szepeshazi K, Schally AV, Treszl A, Seitz S, Halmos G.
    Anticancer Drugs; 2008 Apr 15; 19(4):349-58. PubMed ID: 18454045
    [Abstract] [Full Text] [Related]

  • 18. Swiss 3T3 mouse embryo fibroblasts transfected with a human prepro-GRP gene synthesize and secrete pro-GRP rather than GRP.
    Lebacq-Verheyden AM, Segal S, Cuttitta F, Battey JF.
    J Cell Biochem; 1988 Mar 15; 36(3):237-48. PubMed ID: 3379103
    [Abstract] [Full Text] [Related]

  • 19. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
    Fleischmann A, Waser B, Reubi JC.
    Endocr Relat Cancer; 2009 Jun 15; 16(2):623-33. PubMed ID: 19478282
    [Abstract] [Full Text] [Related]

  • 20. Importance of N- and C-terminal regions of gastrin-Gly for preferential binding to high and low affinity gastrin-Gly receptors.
    Ahmed S, Murphy RF, Lovas S.
    Peptides; 2005 Jul 15; 26(7):1207-12. PubMed ID: 15949639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.